Xylem (NYSE:XYL – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Xylem to post earnings of $0.84 per share for the quarter. Xylem has set its FY 2024 guidance at 4.000-4.200 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter in the prior year, the company posted $0.92 earnings per share. The company’s revenue for the quarter was up 40.6% compared to the same quarter last year. On average, analysts expect Xylem to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Xylem Stock Performance
XYL opened at $130.67 on Thursday. Xylem has a 52-week low of $87.59 and a 52-week high of $132.23. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The company has a market cap of $31.67 billion, a P/E ratio of 48.04, a price-to-earnings-growth ratio of 2.57 and a beta of 1.10. The firm’s 50-day moving average price is $127.30 and its 200-day moving average price is $113.22.
Xylem Increases Dividend
Insider Transactions at Xylem
In other news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have commented on XYL shares. Raymond James upgraded Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Robert W. Baird increased their price objective on Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research note on Thursday, March 21st. Royal Bank of Canada raised their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 7th. BNP Paribas assumed coverage on Xylem in a report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target for the company. Finally, Citigroup increased their price target on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $138.11.
View Our Latest Research Report on XYL
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- High-Yield Texas Instruments Could Hit New Highs Soon
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is Short Interest? How to Use It
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.